RxDoctor Payments Data

Jayshil Patel, MD

Pulmonary Disease · Milwaukee, WINPI 1588830129

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,768 of the $24,655 with a category attached, or 80.2%. 6 manufacturers reported payments, led by Baxter Healthcare at 58.2% of the total. Reporting peaked in 2022 at $9,543 and has fallen 99.6% since, to $36 in 2025. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,655in general payments, 2019–2025

Across 35 payments — averaging $704.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$14K
  • Fresenius Kabi USA, LLC$10K
  • Nestle Healthcare Nutrition Inc.$416
  • Alcresta Therapeutics, Inc.$83
  • Beckman Coulter, Inc.$77
  • Boston Scientific$36

What the payments were for

  • Consulting fees$19,76880%
  • Speaking & faculty fees$1,6757%
  • Travel & lodging$1,4696%
  • Food & beverage$1,7447%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,655 in reported general payments places this provider in the 90th percentile of 247 pulmonary disease providers in Wisconsin.

See all pulmonary disease providers in Wisconsin

Medicare billing

Part B allowed, 2024
$28,631
Medicare patients
79
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →